Pharmaceutical
FDA MedWatch Drug Alerts
- Audience: Consumers BROOKLYN, N.Y., Feb. 27, 2026 /PRNewswire/ — USALESS.COM is recalling its RHINO CHOCO VIP 10X, in 10 gr, 12 pc packages that come in a black cardboard box marked with UPC Code 724087947668 on the back and with an expiration date…
- Shaman Botanicals, LLC Issues Voluntary Nationwide Recall of Alkaloids Chewable Tablets – White VeinAudience: Consumer, Health Care Professional, Pharmacy February 13, 2026 – North Kansas City, Missouri, Shaman Botanicals, LLC is voluntarily recalling one lot (Lot B# AAW.501.3) of Alkaloids Chewable Tablets – White Vein to the consumer…
- Audience: Health Care Professional, Consumer February 12, 2026 — The U.S. Food and Drug Administration has approved drug labeling changes to six menopausal hormone therapy products, also known as hormone replacement therapy (HRT), to clarify risk…
- Audience: Health Care Professional February 5, 2026 — The U.S. Food and Drug Administration (FDA) is providing this communication to increase awareness of recent updates to the product labeling of capecitabine (Xeloda) and fluorouracil (5-FU)…
- Audience: Health Care Professional, Consumer January 13, 2026 FDA Evaluation Did Not Identify an Increased Risk of Suicidal Ideation or Behavior With the Use of GLP-1 RA Medications This information is an update to the FDA Drug Safety…
New Drug Approvals
- BOSTON, March 03, 2026 (GLOBE NEWSWIRE) — Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, announced today that the U.S. Food and Drug…
- SAN RAFAEL, Calif., Feb. 27, 2026 /PRNewswire/ — BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental Biologics License Application (sBLA) for Palynziq…
- PLAINSBORO, N.J., Feb. 27, 2026 /PRNewswire/ — Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a long-acting…
- COPENHAGEN, Denmark, Feb. 27, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food & Drug Administration (FDA) has granted approval under the FDA’s Accelerated Approval Program for Yuviwel…
- Ridgefield, Conn. and Ingelheim, Germany, February, 26, 2026 — The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim’s Hernexeos® (zongertinib tablets) for the treatment of adult patients with advanced non-small cell…
New Drug Applications
- OSAKA, Japan, CAMBRIDGE, Massachusetts and NEWARK, California, March 2, 2026 – Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) today announced that the U.S. Food and Drug Administration…
- THOUSAND OAKS, Calif. – February 23, 2026 – Beren Therapeutics P.B.C.®, the parent company of Mandos LLC® and leader in cholesterol trafficking biology and cyclodextrin-based therapeutics, today announced that the U.S. Food and…
- TARRYTOWN, N.Y., Feb. 19, 2026 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for…
- South San Francisco, CA — February 19, 2026 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application for…
- PRINCETON, N.J.–(BUSINESS WIRE) February 17, 2026 — Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for iberdomide combined with standard treatment…
Clinical Trial Results
- SPRING HOUSE, Pa., (March 3, 2026) – Johnson & Johnson (NYSE: JNJ) today announced that nipocalimaba was granted U.S. Food and Drug Administration (FDA) Fast Track designation as a potential treatment for adults with systemic…
- DUBLIN, March 3, 2026 /PRNewswire/ — Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced topline results from the Phase 3 CYPRESS study evaluating the efficacy and safety of ampreloxetine in…
- BEDFORD, Mass., March 02, 2026 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and…
- South San Francisco, CA — March 1, 2026 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the pivotal Phase III study (FENhance 1) of fenebrutinib in RMS met its primary endpoint, showing clinically…
- RARITAN, N.J., February 26, 2026 – Johnson & Johnson (NYSE:JNJ) today announced preliminary results from a Phase 1b study evaluating pasritamig (JNJ-78278343), a first-in-class bispecific T-cell engaging antibody, in combination with…
Daily Med News
- THURSDAY, March 5, 2026 — If you live in parts of the West and South, you may already be reaching for your allergy meds.Tree pollen is ramping up in those regions, according to AccuWeather.com, which issued its 2026 pollen forecast on Wednesday. "…
- THURSDAY, March 5, 2026 — If you suffer from persistent foot or lower body discomfort, the solution might be found in your closet rather than your medicine cabinet. Podiatrists emphasize that the right footwear does more than just cushion…
- THURSDAY, March 5, 2026 — Deaths linked to pregnancy and childbirth fell slightly in the United States in 2024, new data show. Early data suggests the decrease may have continued into 2025. The U.S. Centers for Disease Control and Prevention…
- THURSDAY, March 5, 2026 — Trader Joe’s is recalling several frozen food items after reports that they may contain small pieces of glass. The grocery chain said four frozen products could be affected and asked customers not to eat…
- THURSDAY, March 5, 2026 — Wrist-worn fitness tracking devices might be able to predict whether a person with multiple sclerosis is more likely to have worsening disability, a new study says. Data from fitness trackers showed not only who was…
News for Health Professionals
- THURSDAY, March 5, 2026 — For patients with asthma, receipt of immune checkpoint inhibitor (ICI) therapy for melanoma or renal cell carcinoma is not associated with an increased risk for exacerbations, according to a study presented at the annual…
- THURSDAY, March 5, 2026 — Younger siblings of peanut-consuming children have an increased risk for peanut sensitization and allergy, which can be mitigated by early introduction of peanuts, according to a study presented at the annual meeting of…
- THURSDAY, March 5, 2026 — In a clinical guideline issued by the American College of Physicians and published online March 2 in the Annals of Internal Medicine, rapid practice points are presented for receipt of respiratory syncytial virus (RSV)…
- THURSDAY, March 5, 2026 — Adults with overweight or obesity regain much of their lost weight after cessation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), according to a review published online March 4 in eClinicalMedicine. Brajan…
- THURSDAY, March 5, 2026 — Past COVID-19 illness increases the risk for kidney disease compared with individuals without COVID-19 and those with past flu infection, according to a study published online Feb. 25 in Communications Medicine. Yue…
